Top news
COVID-19 vaccines for children and teens: What we do — and don't — know
By Kristin Leigh Moffitt
Why we shouldn't panic about the millions who missed their second vaccine dose—yet
By Maya Wei-Haas
India's vaccinations plummet as coronavirus infections soar
By Krishna N. Das
Pfizer-BioNTech Vaccine is Highly Effective Against Variants, Studies Find (Published 2021)
By Emily Anthes
Posts on X
Formerly TwitterWorld Health Organization (WHO)
WHO
Yes, #VaccinesWork!
They have enabled dramatic reductions in illness, disability and death from common childhood diseases.
#WorldImmunizationWeek ➡️ bit.ly/4d0Xl2T pic.twitter.com/TrtmEE6WNz
Posted on X
World Health Organization (WHO)
WHO
Vaccines save lives.
They build futures.
Millions of children are now protected from deadly diseases, but millions are still missing out on life-saving vaccines.
Speak up and tell your leaders it’s time for #immunization for all.
It’s time to show the world what’s… pic.twitter.com/roJO3BieXH
Posted on X
Eric Topol
EricTopol
“A month of doses can be manufactured for less than $5, which means that American customers are paying a 200-fold markup or more, with many of them paying it out of pocket.” @dwallacewells @nytopinion www.nytimes.com/2024/04/24/opinion/ozempic-wegovy-weight-glp1.html
Posted on X
Sputnik V
sputnikvaccine
Scientific American: “Vaccination dramatically lowers #longCOVID risk. Several new studies reveal that getting multiple COVID vaccine doses provides strong protection against lingering symptoms.”👇
www.scientificamerican.com/article/vaccination-dramatically-lowers-long-covid-risk/
Posted on X
All coverage
Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues
By Kevin Breuninger
Pfizer Seeks Full FDA Approval For COVID-19 Vaccine
By Emma Bowman
BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says
By Noah Higgins-Dunn
How the Moderna, AstraZeneca, Pfizer and other Covid vaccines compare
By Annelies Gartner, Anne Gulland & Lizzie Roberts
Pfizer to seek authorization for Covid-19 vaccine for children ages 2 to 11 in September
By Naomi Thomas
Pfizer seeks full FDA approval for COVID-19 vaccine beyond current emergency use
By William Mansell & Eric M. Strauss
FDA preparing to authorize Pfizer Covid vaccine for 12- to 15-year-olds as early as next week
By Lauren Egan & Laura Strickler
Canada allows Pfizer COVID-19 vaccine for children aged 12-15
By David Ljunggren
Pfizer sees robust COVID-19 vaccine demand for years, $26 bln in 2021 sales
By Michael Erman & Manas Mishra
BioNTech nearing request for approval of longer-lasting version of COVID vaccine
By Louise Heavens, Ludwig Burger & Alistair Smout
Pfizer and BioNTech begin the process of seeking full U.S. approval for their Covid vaccine
By Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn Kopecki
Covid-19: F.D.A. to Authorize Pfizer Vaccine for Adolescents by Early Next Week (Published 2021)
By Apoorva Mandavilli, Kate Taylor & Will Wright
Covid-19: Studies Indicate Pfizer-BioNTech Vaccine Protects Against the Most Severe Outcomes of Some Virus ...
By Apoorva Mandavilli, Dan Levin & Thomas Kaplan
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine (Published 2021)
By Rebecca Robbins & Peter S. Goodman
COVID-19 vaccines and kids: What parents should know
By Katie Kindelan